Banque Transatlantique’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Sell
31,530
-170
-0.5% -$15.5K 0.07% 94
2026
Q1
$3.26M Buy
31,700
+13,549
+75% +$1.53M 0.08% 72
2025
Q4
$2.27M Sell
18,151
-397
-2% -$50.6K 0.06% 68
2025
Q3
$2.48M Sell
18,548
-40
-0.2% -$5.25K 0.06% 65
2025
Q2
$2.53M Sell
18,588
-216
-1% -$28.5K 0.07% 58
2025
Q1
$2.49M Sell
18,804
-19,300
-51% -$2.46M 0.08% 55
2024
Q4
$4.31M Buy
+38,104
New +$4.4M 0.11% 50

Other funds holding ABT

Banque Transatlantique's ABT Position: Q2 2026 in Review

Banque Transatlantique reduced its Abbott (ABT) stake by 0.54% in Q2 2026, selling an estimated $15.5K and leaving 31,530 shares worth $3.13M. The position accounts for 0.07% of the portfolio, ranked #94.

Banque Transatlantique first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.31M in Q4 2024. 1,892 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Banque Transatlantique held 31,530 shares of Abbott worth $3.13M as of Q2 2026.
  • Banque Transatlantique sold 170 Abbott shares in Q2 2026, an estimated $15.5K.
  • Abbott made up 0.07% of Banque Transatlantique's portfolio in Q2 2026, its #94 holding.
  • Banque Transatlantique first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Abbott position peaked at $4.31M in Q4 2024.
  • 1,892 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.